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a b s t r a c t
Entry determinants in the XPR1 receptor for the xenotropic/polytropic mouse leukemia viruses
(XP-MLVs) lie in its third and fourth putative extracellular loops (ECLs). The critical ECL3 receptor
determinant overlies a splice donor and is evolutionarily conserved in vertebrate XPR1 genes; 2 of the
3 rare replacement mutations at this site destroy this receptor determinant. The 13 residue ECL4 is
hypervariable, and replacement mutations carrying an intact ECL3 site alter but do not abolish receptor
activity, including replacement of the entire loop with that of a jellyﬁsh (Cnidaria) XPR1. Because ECL4
deletions are found in all X-MLV-infected Mus subspecies, we deleted each ECL4 residue to determine
if deletion-associated restriction is residue-speciﬁc or is effected by loop size. All deletions inﬂuence
receptor function, although different deletions affect different XP-MLVs. Thus, receptor usage of a
constrained splice site and a loop that tolerates mutations severely limits the likelihood of host escape
mutations.
Published by Elsevier Inc.
Introduction
The xenotropic/polytropic mouse leukemia viruses (XP-MLVs) are
gammaretroviruses isolated from laboratory and wild mice that differ
from one another in host range, in their pathogenic potential and their
Mus musculus subspecies of origin (Kozak, 2010). The multiple XP-MLV
host range variants all use the same XPR1 receptor but differ in their
ability to infect cells of their natural Mus hosts and cells of other
mammalian species (Cloyd et al., 1985; Fischinger et al., 1975; Hartley
et al., 1977; Levy, 1973). X-MLVs infect most mammalian species,
whereas P-MLVs infect fewer species, and there are wild mouse XP-
MLV isolates with distinctive host ranges and interference patterns
(Cloyd et al., 1985; Yan et al., 2009). These tropism differences are due
to polymorphisms in the viral envelope (env) glycoprotein and in the
XPR1 receptor.
In Mus species, there are 6 functionally distinct XPR1 receptor
variants resulting from sequence variation in the putative third and
fourth extracellular loops (ECL3 and ECL4) (Bamunusinghe et al.,
2013; Marin et al., 1999; Yan et al., 2009; Yan et al., 2010).
At least six XPR1 residues have roles in virus entry, 3 in ECL3 and
3 in ECL4 (Marin et al., 1999; Yan et al., 2007; Yan et al., 2010).
Substitutions at these sites result in restriction of one or more of the
viruses that use this receptor. Two of these sites are particularly
important for X-MLV infection: K500 in ECL3 and T582 in ECL4 (Marin
et al., 1999). Both of these sites are mutated in the X-MLV-restrictive
Xpr1n variant, found in the majority of laboratory mouse strains.
Repair of either of these sites is sufﬁcient to generate a receptor for
X-MLVs, demonstrating the presence of two independent X-MLV
receptor determinants in this protein, and there is evidence that
receptor function is modulated by cooperativity between these sites
and by involvement of other residues (Yan et al., 2009).
With very few exceptions, mammalian XPR1 proteins have
X-MLV receptor function (Xu and Eiden, 2011). This scarcity of
escape mutations results in part from the fact that the critical ECL3
residue, K500, is evolutionarily conserved, and by the fact that
functional X-MLV receptors can carry multiple substitutions in
ECL4 (Yan et al., 2010). Among mammalian XPR1 receptors, ECL4
deletions are only found inM. musculus subspecies. Three different
in-frame deletions mark different lineages of house mice: Xpr1c
(M. m. castaneus), Xpr1m (M. m. molossinus andM. m. musculus) and
Xpr1n (laboratory mice and M. m. molossinus). These deletions
remove residues in an 8 residue stretch in the 13 residue ECL4
(Marin et al., 1999; Yan et al., 2010) (Fig. 1A). Each of the 3 deleted
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receptors inhibits two or more viruses in the XP-MLV family, and
the appearance of these restrictive variants in Mus evolution
coincides with the acquisition of X-MLV endogenous retroviruses
(ERVs) in these 3 subspecies (Bamunusinghe et al., 2013; Kozak,
2013; Kozak and O’Neill, 1987). The fact that three different
deletions lie in this receptor-determining loop suggests either that
the six deleted residues are important for receptor function, or
alternatively, that altering the size or structure of this ECL may be
a particularly effective way to disable or modify receptor function
in mice that harbor mutagenic and pathogenic viruses.
To assess whether the 6 residues deleted in M. musculus XPR1 are
critical for entry, or whether it is the size of the ECL4 loop that is
important for receptor function, we evaluated receptor function for
XPR1 constructs in which each one of the 13 ECL4 residues was
deleted. We also replaced the entire ECL4 with the corresponding
segment of the very divergent jellyﬁsh (Cyanea capillata) XPR1
ortholog to assess the limits of receptor tolerance for major sequence
variation. Finally, we screened XPR1 orthologs in 60 sequenced
vertebrate genomes for sequence variations, and we evaluated the
replacement mutations found at receptor-critical sites for possible
roles in virus entry.
Results
A fortuitous receptor choice: the K500 XPR1 receptor determinant
overlaps a splice donor site
The site in the XPR1 ECL3 with the greatest inﬂuence on
receptor function is K500. Most mammals are susceptible to
XP-MLVs, and K500 is completely invariant in the mammals we
examined previously with the single exception of the X-MLV-
restrictive laboratory mouse which carries E500 (Fig. 1A) (Yan
et al., 2010). In the avian lineage, the homologous site, K496, is also
critical for XPR1 receptor function, and avian XPR1 receptor
function can be disabled by two naturally occurring mutations at
this site, K496E and K496Q (Martin et al., 2013). The mouse
mutation and both bird mutations all result from substitutions in
Fig. 1. Sequence variation at receptor critical sites in XPR1. (A) Protein sequence in the C-terminal end of ECL3 and ECL4 in fully susceptible Xpr1sxv and in M. musculus
variants carrying ECL4 deletions. Virus infectivity patterns are shown for each naturally occurring receptor and for Xpr1n mutants with corrections at the two X-MLV receptor
sites. Log10 titer: þ , 1–2; þþ , 43. (B) DNA sequence spanning the exon/intron junction at the end of XPR1 exon 11. Nucleotide distribution in the splice donor consensus
site is from (Mount, 1982). Sequences are shown for variants in mammals and other vertebrates.
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the ﬁrst position of this codon (CAA and GAA). The fourth possible
substitution at this position generates a stop codon. The second
and third positions in codon 500 overlap the consensus splice
donor site at the end of Xpr1 exon 11 (Fig. 1B). Although the
consensus sequence allows all 4 bases at these two positions (3
and 2 relative to the splice site breakpoint), frequencies of some
bases are greatly reduced, imposing some constraints on sequence
variation (Mount, 1982).
While the ECL3 receptor determinants in bird and mouse
XPR1are disabled by the equivalent mutations K496E and K500E,
the functional consequences of K496/500Q have only been exam-
ined in some species of fowl. To determine if this mutation can
affect virus entry in the context of other XPR1 sequence variants,
we introduced K500Q into the fully functional Xpr1sxv receptor
(Fig. 1A). Receptors were expressed in E36 Chinese hamster cells
and evaluated for function using lacZ pseudotypes carrying Env
glycoproteins of 4 XPR1-dependent viruses: the CAST-X X-MLV,
FrMCF P-MLV and two wild mouse viruses, CasE#1 and Cz524,
with atypical host range (Fig. 1A). The Xpr1sxv–K500Q mutant was
able to transduce all 4 XP-MLVs, although with reduced efﬁciency
(Fig. 2, top row). Because X-MLV entry is effected independently by
K500 in ECL3 and T582 in ECL4 (Marin et al., 1999), the presence of
T582 in this construct may fully account for the observed receptor
function. Therefore, we also introduced Q500 into Xpr1n to
determine if Q500 could, like K500, compensate for the Xpr1n
ECL4 mutation T582Δ and generate an X-MLV receptor (Fig. 1A).
Of the 4 tested pseudoviruses, only FrMCF is transduced by wild
type Xpr1n (Fig. 2, bottom row), and this was also the only
pseudovirus that utilized the mutated Xpr1n-E500Q receptor,
indicating that this substitution does not function as an X-MLV
receptor determinant in the context of either the avian or the Mus
XPR1 and that it has minimal inﬂuence on P-MLV entry.
We looked for additional naturally occurring substitutions
in vertebrate XPR1 orthologs at the exon 11 splice donor. XPR1
orthologs have been identiﬁed in at least 66 eukaryotic species
(http://useast.ensembl.org/Mus_musculus/Gene/Compara_Ortho-
log?db¼core;g¼ENSMUSG00000026469;r¼1:155,275,701–155,
417,415). Among the 60 vertebrate XPR1 orthologs, we found only
one other replacement mutation at codon 500. This codon, AGA,
encodes R500 and is found in the anole lizard and in pika (Fig. 1B).
Fig. 2. Susceptibility of E36 hamster cells expressing Xpr1 ECL3 mutants to LacZ XP-MLV pseudoviruses carrying the indicated Env glycoproteins. Titers represent blue cells in
50 μl of virus stock and are presented as the means of 3–5 tests plus SEM. The asterisks indicate signiﬁcant p-Values using Student's t-test (*, po0.05; **, po0.01; ***,
po0.001; ****, po0.0001). Untransfected E36 cells show trace levels of susceptibility to CAST-X (log10¼0.270.3). Graphs at the top show mutants introduced into Xpr1sxv,
with transfectants expressing the sxv wild type in black. Graphs at the bottom show mutants of Xpr1n mutants, and the n wild type is in white. Westerns showing V5-tagged
receptor expression in each transfectant are at the bottom.
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Introduction of this mutation into the Mus Xpr1sxv construct
produces a protein that is functional as a receptor for 4 XP-MLVs
(Fig. 2, top row). In Xpr1n, R500, like K500, supports entry of 3 XP-
MLVs, but not CasE#1 (Fig. 2, bottom), so this rare mutation is thus
functionally equivalent to the wild type K500.
The tolerance of functional XPR1 receptors for sequence variation in
ECL4
A comparative analysis of the 13 residue XPR1 ECL4 sequence
in various mammals showed extensive sequence hypervariation
and identiﬁed only 3 conserved residues (S578, T580, G589), the
ﬁrst 2 of which are also conserved in avian XPR1s (Martin et al.,
2013; Yan et al., 2010). Sequence variation at the other 10 ECL4
residues is compatible with receptor function, as virtually all
mammalian orthologs are functional as X-MLV receptors (Kozak,
2010). Comparison of protein sequences across a larger and more
diverse set of 60 vertebrates shows that none of the 13 residues is
conserved among these species (not shown). To deﬁne the limits
of ECL4 sequence variation in functional receptors we evaluated
3 sets of replacement mutations in the Mus Xpr1 ECL4 for their
effects on virus entry.
First, because ECL4 variations in 5 of the 6 previously char-
acterized Mus XPR1s restrict virus entry, we examined a seventh
naturally occurring Mus XPR1 variant, carrying the ECL4 substitu-
tion K585R, found in the African pygmy mouse, Mus tenellus
(Fig. 3) (Yan et al., 2010). Introduction of K585R into Xpr1sxv did
not appreciably alter receptor function (Fig. 4, top row). To
determine if the K585R-containing ECL4 has a functional receptor
determinant in the absence of the ECL3 determinant K500, we also
introduced K585R into Xpr1n-Δ582T, a construct which carries
E500 and a full length ECL4 (Fig. 1A), but again, no change in
receptor phenotype was noted (Fig. 4, bottom row). These results
indicate that the conservative substitution of K585R does not
detectably affect virus-receptor interactions. That M. tenellus is
thus likely to have a fully functional XPR1 receptor is not surpris-
ing, as this species, in the subgenus Nannomys, diverged from
other Mus species well before virus exposure resulted in acquisi-
tion of X-MLV endogenous retroviruses in M. musculus, subgenus
Mus, and the coincident appearance of restrictive receptors (Kozak,
2013; Kozak and O’Neill, 1987; Yan et al., 2010).
Second, our analysis of avian species had identiﬁed an ECL4
mutation that disables avian XPR1 receptor function, Q579E, a site
which aligns with two adjacent Thr residues (T582, T583) in Mus
Xpr1, deletion of one of which, T582Δ, in the restrictiveMus Xpr1n,
is receptor critical (Marin et al., 1999; Martin et al., 2013). To
determine whether this mutation alters receptor function in the
XPR1 orthologs of other species, we introduced the replacement,
T583E, into mouse Xpr1sxv, which is 83% identical in protein
sequence to the chicken XPR1, but only 38% identical in ECL4
(Fig. 3). Transfected E36 cells were able to transduce all 5 XP-MLVs,
but susceptibility to FrMCF, but not MoMCF, was reduced over
100-fold (Fig. 4, top row). We also introduced T583 into Xpr1n-
Δ583T; infection was not detected for 4 of the 5 viruses (Fig. 4,
bottom row). This site is therefore a key receptor determinant, and
the T583E mutation results in loss of the ECL4 receptor determi-
nant in the very different bird and mammalian receptors.
Finally, we tested the functional limits of ECL4 sequence
variation by replacing the ECL4 of Xpr1sxv with the equivalent
region from the highly divergent ortholog of a primitive metazoan
(Fig. 3). The XPR1 ortholog of cnidarians (jellyﬁshes, corals, sea
anemones, Hydra) was isolated from Cyanea capillata (a jellyﬁsh,
class: Scyphozoa) using degenerate primers for GCPRs. A novel
sequence encoding a protein of 675 amino acids (deduced MW 78
813) was obtained from a cDNA library enriched in neurons.
Although 600 million years separate mammals from members
of this phylum, the sequence shows signiﬁcant homology with
mammalian XPR1 and also with the XPR1-related PHO1 sequence
of plants; the CcXPR1 sequence is 49% identical to Mus Xpr1. The
sequence in the region corresponding to ECL4 is quite divergent,
although there is signiﬁcant sequence homology upstream and
downstream of the ECL4 segment.
Expression of the jellyﬁsh CcXPR1 in E36 hamster cells resulted
in no detectable transduction of any XP-MLV (not shown). We
generated a chimeric Xpr1 by replacing ECL4 of Xpr1sxv with that
deduced for CcXPR1 (Fig. 3). E36 transfectants expressing the
MuCcXPR1 chimera showed signiﬁcant susceptibility to X-MLV
and MoMCF, and 2–4 log (100–10,000 fold) reductions in suscept-
ibility to FrMCF and the 2 wild mouse viruses (Fig. 4, top row).
Introduction of the K500E mutation at the critical ECL3 receptor
site into this chimera eliminated most receptor functions (Fig. 4,
bottom row), although trace levels of infection were detected for
most viruses. This indicates that the substantially different ECL4 of
jellyﬁsh can contribute to an active XP-MLV receptor in the context
of a functional Mus XPR1 carrying K500.
The effect of ECL4 deletion mutations on receptor function
Among mammalian species, only the 3 XP-MLV infected M.
musculus lineages carry Xpr1 receptors that restrict virus entry due
to 3 different in-frame deletions in ECL4: deletion of T582 in Xpr1n,
deletion of I579 in Xpr1m and the 5-residue T582-P586 deletion in
Xpr1c (Fig. 1a). Unlike Xpr1n, the Xpr1m and Xpr1c receptors carry
K500 in ECL3 as does the permissive Xpr1sxv. To determine if the
effects of these various deletions on receptor function are due to
loss of key residues or to a structural change resulting from
reduction in loop size, we assessed receptor function after removal
of each of 12 ECL4 residues from Xpr1sxv.
All of the deleted receptors were able to transduce the two
X-MLVs (CAST-X and XMRV) (Fig. 5), although deletion of I579
substantially reduced infection by both X-MLVs as shown
previously (Yan et al., 2010). Deletion of residue T583 did not
affect X-MLV receptor function as demonstrated previously for
deletion of T582 (Marin et al., 1999). Infection with the 2 wild
mouse pseudoviruses (Cz524 and CasE#1) was sensitive to
multiple residue deletions, especially residues in the more
N-terminal end of this ECL, positions 578–586. This segment
includes the 6 residues deleted in Xpr1m, Xpr1n, or Xpr1c, and
these 3 Mus orthologs all show restricted infection with these
2 viruses (Kozak, 2010) (Fig. 1A).
Fig. 3. Naturally occurring ECL4 mutations introduced into Xpr1sxv. K585R was
found in the African pygmy mouse, M. tenellus, and T583E is equivalent to the
Q579E mutation in the restrictive chicken XPR1. At bottom is a chimera in which
the ECL4 of Xpr1sxv is replaced by the homologous segment from the jellyﬁsh,
C. capillata.
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Infection with two P-MLVs, FrMCF and MoMCF, was reduced for
nearly all of the deletions, but different patterns were observed for
these two P-MLVs. Deletions of S578, F584 and K585 largely abolish
infection by FrMCF, but not by MoMCF (Fig. 5). This receptor-mediated
tropism difference for two viruses in the P-MLV host range group was
also seen for MuCcXpr1 and T583E (Fig. 4) and is consistent with their
previously observed differential infectivity for mutated Mus Xpr1
receptors (Yan et al., 2009). This conﬁrms that there are different host
range subgroups among polytropic MLVs.
Because this set of deletions was made in Xpr1sxv, it is likely that
the presence of K500 contributed to their ability to transduce X-MLVs.
Therefore, we made a second set of 7 deletions spanning the ECL4
of Xpr1n-Δ583T, which has E500 (Fig. 1A). All 7 deletions restrict
infectivity by CAST-X X-MLV by at least 1000-fold (Fig. 6), indicating
that the X-MLV receptor determinant in ECL4 is not strictly deﬁned by
T582 as previously thought, and suggesting either that these deletions
may result in a structural change in this loop that impacts receptor
function or that the receptor interface extends over this entire loop.
These 7 deletions also nearly eliminate infection by 2 wild mouse
viruses (Fig. 6) indicating that these viruses rely on K500 as well as
determinants in ECL4 as shown in Fig. 5.
These 7 deletions, however, minimally reduced infection by the
two P-MLVs (Fig. 6). Also, this deletion set did not show the same
differential sensitivity of FrMCF and MoMCF for deletions of S578,
F584 and K585 as seen in the Xpr1sxv constructs (Figs. 5 and 6). The
Xpr1nΔ582T constructs differ from Xpr1sxv at another ECL4 site,
D590N (Fig. 1A). To assess whether residues at position 590 are
responsible for this infectivity difference, we added the mutation
N590D to Xpr1n-Δ583T,K585Δ (Fig. 6, lower right). MoMCF
replication was unchanged by this substitution, but FrMCF showed
reduced infectivity in the presence of D590, explaining the
observed differences between the two sets of constructs.
The data taken together indicate that the XP-MLV subtypes
respond differently to ECL4 deletions: X-MLV entry is sensitive to
deletions throughout ECL4 when the K500 receptor determinant
is not present, the wild mouse viruses are also sensitive to
N-terminal ECL4 deletions in the presence of K500, and the two
P-MLV isolates differ in sensitivity to ECL4 sequence variants
deﬁning two distinct P-MLV host range subgroups.
Discussion
XPR1 acts as a functional mouse gammaretrovirus receptor in
virtually all mammalian species. The scarcity of XPR1 escape
mutations lacking all receptor function is due in large part to the
fact that virus entry relies on independent receptor determinants
in XPR1, and because, as shown here, the two redundant sites for
Fig. 4. Susceptibility of E36 hamster cells expressing Xpr1 ECL4 replacement mutants to LacZ XP-MLV pseudoviruses. Titers represent blue cells in 50 μl of virus stock and
graphs were produced as in Fig. 2. Untransfected E36 cells are poorly infectious for CAST-X (log10¼0.470.4). Graphs at the top show mutations introduced into Xpr1sxv.
Graphs at the bottom show Xpr1nΔ582T mutants. At the bottom are westerns showing receptor expression.
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X-MLV entry include one which overlaps a constrained splice
donor, while the other determinant, in the short ECL4 loop, is
marked by signiﬁcant sequence variation. Speciﬁc residue replace-
ments or deletions in ECL4 can affect but not eliminate all receptor
function, and replacement of the entire ECL4 with the correspond-
ing sequence of the jellyﬁsh does not, by itself, abolish receptor
function.
It has long been recognized that virus-receptor interfaces are
evolutionary battleﬁelds in an “arms race” in which hosts evolve to
avoid infection, and viruses evolve to bypass host restrictions. It is
clearly disadvantageous to harbor an infectious agent that is patho-
genic and mutagenic, and host species can inhibit virus entry through
hypomorphic mutations that downregulate receptor expression,
through factors that interfere with receptor binding, or through
mutations that alter the virus-receptor interface. Virus survival
depends on factors that minimize the consequences of the host escape
mutations that inhibit replication. At the level of entry, multiple
strategies can circumvent host restrictions. One possible survival
mechanism is receptor switching, but the repertoire of alternative
receptors for gammaretroviruses is restricted to multipass transmem-
brane proteins. Another strategy is the usage of functionally redundant
binding sites, so that single receptor mutations cannot disable receptor
function. Thus, for XPR1, separate mutations in the receptor-
determining regions of ECL3 or ECL4 do not abolish receptor function,
and most mutations with detectable effects restrict some but not all
XP-MLVs. Thus, for example, P-MLVs and the wild mouse isolates are
sensitive to speciﬁc ECL4 deletions, and I579Δ effectively restricts all
but CAST-X.
Yet another virus survival mechanism involves use of receptor
determinants that are also important for the protein's normal
Fig. 5. Susceptibility of E36 hamster cells expressing Xpr1sxv ECL4 deletion mutants to LacZ XP-MLV pseudoviruses. Untransfected E36 cells are poorly infectious for CAST-X
(log10¼1.270.6). Graphs were produced as for Fig. 2. Red arrows mark titer differences between FrMCF and MoMCF. At the bottom are westerns showing XPR1 expression.
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function. This limits mutations that could decrease the ﬁtness of
the host species, and usage of such sites provides viruses with a
reliable port of entry. Our previous phylogenetic analyses demon-
strated that XPR1 shows signatures of positive selection in rodent
and avian lineages (Martin et al., 2013; Yan et al., 2010). While
some of these mutational changes may be linked to the host cell
function of XPR1, published evidence suggests that this protein has
roles in phosphate export or in signal transduction (Giovannini
et al., 2013; Vaughan et al., 2012). On the other hand, restrictive
XPR1 receptors are found in X-MLV-exposed rodent and avian
species, and the sites under positive selection in both lineages
govern antiviral activity. Although these mutational patterns have
as yet no known link to XPR1 function, there is, however, a clear
functional constraint on mutational variation in Xpr1 as the codon
for the ECL3 receptor determinant K500 overlaps a splice donor
site. The rarity of substitutions in this codon in vertebrate species
indicates that this was a fortuitous receptor choice. Of the three
naturally occurring replacement mutations at K500, two, K500E
and K500Q, are found in mouse and/or avian species exposed to
X-MLVs, and both mutations eliminate an XP-MLV receptor deter-
minant. On the other hand, K500R is found in two vertebrate
species not likely to have had virus exposure, and this mutation
has no inﬂuence on receptor function.
In M. musculus subspecies, three restrictive alleles are disabled
by ECL4 deletions: Xpr1n in laboratory mice and some M. m.
molossinus, Xpr1c in M. m. castaneus and Xpr1m in M. m. musculus
and molossinus (Bamunusinghe et al., 2013; Kozak, 2010). These
3 deletions remove different residues in 8 residue stretch of this
13-residue loop. Mutational analysis showed that in the presence
of K500, all XP-MLVs except for X-MLVs are sensitive to deletions,
especially within the N-terminal end of this loop. In the presence
of the K500E mutation, however, deletions throughout ECL4
effectively reduce receptor function for X-MLV and the wild mouse
viruses. These data suggest that the length or structure of this loop
is important for X-MLV receptor function and that residues nearer
to the N-terminus are especially important for other XP-MLVs.
The XPR1 ECL4 sequence is highly variable among mammalian
orthologs that encode functional receptors. Mutation of Xpr1sxv to
evaluate two naturally occurring replacement mutations and the
replacement of this loop with that from the nonfunctional Cnar-
dian XPR1 receptor produced some reductions in receptor func-
tion. The functional reduction for MuCcXpr1 could be due to the
ECL4 size difference as well as the sequence variation. In the
presence of the K500E mutation, however, receptor function was
largely eliminated by T583E and the jellyﬁsh replacement. These
results establish the importance of speciﬁc residues for the ECL4
receptor determinant, and show that while the jellyﬁsh XPR1 does
not contain an ECL4 virus attachment site, the presence of this
divergent sequence does not disrupt construction of the K500
receptor site.
Finally, P-MLVs and X-MLVs use different XPR1 receptor deter-
minants (Van Hoeven and Miller, 2005; Yan et al., 2009). Our data
show that the Friend and Moloney MCF P-MLVs show distinctive
receptor-deﬁned tropisms although both are classed as polytropic
with some differences in species host range (Cloyd et al., 1985; Yan
et al., 2010). This variation in receptor usage by the poly-
tropic viruses likely results from the fact that infectious P-MLVs
are recombinants that contain ERV-derived env segments that
differ in sequence and size (Chattopadhyay et al., 1982). Deletions
of 3 particular ECL4 residues (S578, F584, K585) had pro-
foundly different consequences for infection by these two P-MLVs,
as did the jellyﬁsh/mouse chimera, indicating that MoMCF is more
Fig. 6. Susceptibility of E36 hamster cells expressing Xpr1 ECL4 mutants to LacZ XP-MLV pseudoviruses. Mutations were done in Xpr1nΔ582T which carries the ECL3
mutation K500E. Graphs were produced as for Fig. 2. The extra panel on the lower right shows the effect of residues at position 590 on P-MLV infection. Westerns are
presented on the lower left.
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accommodating of receptor variation. Further analysis of one of
those deletions, K585Δ, showed that this differential infectivity is
modulated by residues at ECL4 position 590, a site not previously
shown to contribute to receptor function.
Conclusions
The XPR1 protein functions as a gammaretrovirus receptor in
nearly all mammals. This is because it carries 2 functionally
independent receptor determinants, one of which overlies a splice
donor site and is therefore evolutionarily constrained. The second
site lies in a short extracellular loop that shows signiﬁcant natural
sequence variation due to replacement and deletion mutations.
The great majority of mutations at one or the other of these
receptor-determining that regions have minimal effects on recep-
tor function, including replacement of the entire ECL4 with that of
the jellyﬁsh XPR1; when both receptor regions are mutated,
different mutations inhibit entry of different XP-MLV subtypes.
Materials and methods
Viruses
CAST-X is an X-MLV isolated in our laboratory from the spleen
of a CAST/EiJ mouse (Yan et al., 2007). Cz524 is a novel MLV
isolated from the spleen of a CZECHII/EiJ mouse 2 months after
inoculation with MoMLV (Yan et al., 2009). The human xenotropic-
related virus, XMRV (Dong et al., 2007), was kindly provided by
R. Silverman (Cleveland Clinic, Cleveland, OH). CasE#1 (Cloyd
et al., 1985), the Friend mink cell focus inducing P-MLV (FrMCF),
and Moloney MCF P-MLV (MoMCF) were originally obtained from
J. Hartley (NIAID, Bethesda, MD).
Pseudotype assay and western analysis
Viral pseudotypes carrying the LacZ reporter were generated by
infecting GP2-293 cells transfected with pCL-MFG-LacZ with the
various XP-MLVs as described previously (Yan et al., 2009).
E36 Chinese hamster cells (Gillin et al., 1972) were transfected
with variants of mouse Xpr1. Stable transfectants were generated
using Fugene6 (Promega, Madison, WI) and selected with genet-
icin (830 μg/ml) (Corning Cellgro, Manassas, VA). Cells were
infected with dilutions of the pseudotype virus stocks in the
presence of 4–8 μg/ml polybrene (Aldrich, Milwaukee, WI). One
day after infection, cells were ﬁxed with 0.4% glutaraldehyde and
assayed for β-galactosidase activity using as substrate 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-Gal, 2 mg/ml; ICN Bio-
medicals, Aurora, Ohio). Infectious titers were determined from
the number of blue cells per 50 μl of virus supernatant.
Proteins were extracted from transfected cells with M-PER
Mammalian Protein Extraction Reagent (Pierce, Rockford, IL).
Western blots were used to conﬁrm expression of tagged XPR1
using anti-V5 antibody (Invitrogen, Carlsbad, CA) followed by goat
anti-mouse IgG conjugated with HRP (Invitrogen). The membrane
was then stripped and incubated with mouse anti-α-tubulin
(Sigma, St. Louis, Mo) and the goat anti-mouse IgG.
Table 1
Primers for cloning and mutagenesis.
Deletion mutationsa
S578Δ CGCTTGGACTATCCAAATCATTACTGCTACAACG
I579Δ GACTATCCAAATCTCTACTGCTACAACGTTTAAGC
T580Δ CGCTTCGCTTGGACTATCCAAATCTCTATTGCTACAACG
A581Δ CGCTTGGACTATCCAAATCTCTATTACTACAACGTTTAAGCC
T583Δ CAAATCTCTATTACTGCTACATTTAAGCCTCATGTTGGG
F584Δ CCAAATCTCTATTACTGCTACAACGAAGCCTCATGTTGGGG
K585Δ CTATTACTGCTACAACGTTTCCTCATGTTGGGGACATCATTGC
P586Δ CTATTACTGCTACAACGTTTAAGCATGTTGGGGACATCATTGC
H587Δ GCTACAACGTTTAAGCCTGTTGGGGACATCATTGC
V588Δ GCTACAACGTTTAAGCCTCATGGGGACATCATTGCTACTG
G589Δ CGTTTAAGCCTCATGTTGACATCATTGCTACTG
D590Δ GCTACAACGTTTAAGCCTCATGTTGGGATCATTGCTACTG
K585Δ (in Xpr1n) CTATTACTGCTACAACGTTTCCTCATGTTGGGAACATCATTGC
H587Δ (in Xpr1n) GCTACAACGTTTAAGCCTGTTGGGAACATCATTGC
G589Δ (in Xpr1n) CGTTTAAGCCTCATGTTAACATCATTGCTACTGTCTTTGCC
Replacement mutationsa
K500R GCCCTTTACAGCACTCACAGAGAACAAAACCACTC
T583E CTCTATTACTGCTACAGAGTTTAAGCCTCATGTTGGGGAC
K500Q GCCCTTTACAGCACTCACCAAGAACAAAATCACTC
K500E GCCCTTTACAGCACTCACGAGGAACAAAATCACTC
K585R ACGTTTAGACCTCATGTTGGGG
Cyanea XPR1 cloning
TM2 ATCYTCAACCTKGCYMTSGCMGA
TM7 CAGGAAGGCGTARAGRAMKGGRTT
CcXPR1-HindIII GGGGAAGCTTAAGTTCACAGAACACTTAGGTGCACAC
CcXPR1-NotI GGGGGCGGCCGCTCATCAAACGGTTCTAACAGCGCCATTTTGCTGCG
Mouse/jellyfish chimerab
A GCTGGAGTAAATCATGTCCTC
B caccgaccgaGATTTGGATAGTCCAAGCGAA
C ATCCAAATCtcggtcggtgaggctggc
D GGGCAAAGACAGTAGCAATGATttcgttgttgatgaagcc
E caacaacgaaATCATTGCTACTGTCTTTGCCCCCCTTGAGG
F CAGAAGCCATAGAGCCCACCGCATC
a Reverse primers were reverse complements.
b Jellyﬁsh sequence shown in lowercase letters.
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Cloning of the Cyanea capillata XPR1 sequence
The initial fragment of the jellyﬁsh (Cyanea capillata) XPR1
was obtained from a cDNA λgt22 phage library made from peri-
rhopalial tissues (consisting of neurons, myoepithelial cells,
endoderm, and mesoglea) using a degenerate PCR ampliﬁcation
strategy designed to amplify opioid-like and somatostatin recep-
tors (Marchese et al., 1998) (Table 1). BLASTn searches revealed
homology to XPR1. Five prime and 30 ends of the XPR1 cDNA were
PCR ampliﬁed using oligonucleotides deduced from the XPR1
initial fragment, and an oligonucleotide speciﬁc to the phage arms
(Table 1). The cDNA was initially cloned in-frame into oocyte
expression vector EGFP-PXOOM (Jespersen et al., 2002), a gift from
D.Y. Boudko (Rosalind Franklin University, Chicago, IL), and was
subsequently transferred into the pcDNA3.1/V5-His TOPO (Invitro-
gen, Carlsbad, CA). RT-PCR was used to conﬁrm expression of the
full-length XPR1 cDNA in the peri-rhopalial tissue. The CcXPR1
cDNA sequence is publicly available in GenBank (accession num-
ber: KF638274).
Generation of Xpr1 mutants
Variants of the mouse Xpr1 gene with replacement or deletion
mutations were generated by mutagenesis PCR using QuikChange
II XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) using
as templates previously described clones of Xpr1n-Δ582T and
Xpr1sxv (Yan et al., 2007) (Fig. 1A). Mutations were produced using
the primers and their reverse complements listed in Table 1.
Twelve deletion mutations were produced for the 13 residue
ECL4 because there are adjacent T residues at positions 582
and 583.
ECL4 (39 bp) of Xpr1sxv was replaced with the corresponding
sequence of jellyﬁsh XPR1 (33 bp) using overlap extension PCR.
Forward primer A within the vector (Table 1) was used with
antisense primer B at the 50end of ECL4 to amplify upstream
sequence from mouse Xpr1sxv, and forward primer E at the 50end
of Xpr1 and downstream vector primer F ampliﬁed the down-
stream sequence. Primers B and E were designed with overlapping
CcXPR1 ECL4 overhangs. Primers C and D were then used to
amplify CcXPR1 ECL4 with mouse overhangs. Fragments AB and
CD were used to generate AD, and fragments AD and EF were used
to make AF. Fragment AF and mouse Xpr1sxv were digested with
PﬂMI and EcoRV, which cut at sites that ﬂank ECL4, and the pieces
were ligated to create Xpr1sxv carrying CcXPR1 ECL4, termed
MuCcXPR1. K500E was introduced into this clone to create
MuCcXPR1-K500E.
All mutants were conﬁrmed by sequencing.
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